Since UGT enzymes contribute to the metabolism of asciminib, for severe HI, a ‘modified Sim-Cirrhosis CP-C’ population, accounting for the reduced activity of UGT2B7 and UGT1A4 in such patients, was also used. This evidence concerns the gene UGT2B7 and Cirrhosis.